from Reuters: Business News https://ift.tt/2ygVyVx
Friday, October 12, 2018
Abbvie settles Humira patent disputes with Novartis unit
Abbvie Inc said on Thursday it settled all patent disputes with Novartis AG, granting it a non-exclusive license to manufacture and sell a copycat version of blockbuster drug, Humira.
from Reuters: Business News https://ift.tt/2ygVyVx
from Reuters: Business News https://ift.tt/2ygVyVx
Related Posts:
Evelyn Y. Davis, a Shareholder Scourge of C.E.O.s, Dies at 89- Midterm Elections Deliver a Ratings Surge, With Fox News in the Lead
- The Trade War Left Its Mark on the U.S. Electoral Map
- What Democratic Control of the House Could Mean for Your Wallet
- Facebook Had a Good Election Day. But It Can’t Let Up Now.
0 comments:
Post a Comment